← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2002Last known activity
Feb 5, 2024
Timeline
1930s
- Jan 1, 1932
TNO— Founded
Drugs by trial phase (32 distinct, 17 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (27 own, 0 via acquisition)
Indications
Studied for
Recent trials (36)
- NCT06230900CollaboratorN/AFeb 5, 2024
- NCT02575131Reponsible party - principal investigatorPhase 2Oct 31, 2015
- NCT02575131Lead sponsorPhase 2Oct 31, 2015
- NCT02575131Overall official - principal investigatorPhase 2Oct 31, 2015
- NCT02385149CollaboratorN/AJan 31, 2015
- NCT02064205Sponsor investigatorPhase 2May 1, 2014
- NCT02064205Lead sponsorPhase 2May 1, 2014
- NCT01889147Reponsible party - principal investigatorEarly Phase 1Jun 1, 2013
- NCT01889147Lead sponsorEarly Phase 1Jun 1, 2013
- NCT01738906Lead sponsorN/AOct 31, 2012
- NCT01738906Sponsor investigatorN/AOct 31, 2012
- NCT01241201Lead sponsorN/AOct 1, 2010
- NCT01241201Overall official - principal investigatorN/AOct 1, 2010
- NCT00918918Lead sponsorN/AAug 31, 2009
- NCT00918918Overall official - principal investigatorN/AAug 31, 2009
Details
- Founded
- The Hague, NL Jan 1, 1932
- Last known activity
- Feb 5, 2024